Keep up with the literature and contribute to your community with Biomed News

Are you struggling to keep on top of the literature in your field? Because I know I was, using keyword searches and alerts for tables of contents. In the first week of June 2022 32,294 entries were added to PubMed – an enormous amount of information is being made available every week and is increasing all the time. This makes it hard for researchers, like … Continue reading Keep up with the literature and contribute to your community with Biomed News

Designing therapeutic siRNAs

Short Interfering RNA (siRNA) has come of age to unleash its full potential as a potent therapeutic. The onset of a series of FDA approvals of the siRNA medication targeting rare, previously untreatable genetic disorders and several other promising drug candidates in clinical trials have established the RNA Interference (RNAi) technology in the therapeutic realms. Designing a highly effective siRNA is one of the critical challenges of its downstream usage as a potential drug. Continue reading Designing therapeutic siRNAs

Anti-CD47 antibody: A new hope for cancer treatment

The efficiency and precision of cancer treatments, which may be surgical removal, radiotherapy, chemotherapy, or a combination of second and third depends upon the stage and type of cancer. Targeting CD47 and Signal inhibitory receptor alpha protein interactions (SIRPĪ±) has evolved as one of several such methods of cancer therapy. Continue reading Anti-CD47 antibody: A new hope for cancer treatment